These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30046961)

  • 1. Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation.
    Agirbasli M
    J Thromb Thrombolysis; 2018 Nov; 46(4):570. PubMed ID: 30046961
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-valvular atrial fibrillation: potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants.
    Boriani G; Cimaglia P; Fantecchi E; Mantovani V; Ziacchi M; Valzania C; Martignani C; Biffi M; Diemberger I
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):491-6. PubMed ID: 25575278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in the benefit of the novel oral anticoagulant agents in patients with non-valvular atrial fibrillation.
    Patti G; Cavallari I
    Intern Emerg Med; 2015 Apr; 10(3):395-6. PubMed ID: 25487959
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards.
    Proietti M; Antoniazzi S; Monzani V; Santalucia P; Franchi C; ; Fenoglio LM; Melchio R; Fabris F; Sartori MT; Manfredini R; De Giorgi A; Fabbian F; Biolo G; Zanetti M; Altamura N; Sabbà C; Suppressa P; Bandiera F; Usai C; Murialdo G; Fezza F; Marra A; Castelli F; Cattaneo F; Beccati V; di Minno G; Tufano A; Contaldi P; Lupattelli G; Bianconi V; Cappellini D; Hu C; Minonzio F; Fargion S; Burdick L; Francione P; Peyvandi F; Rossio R; Colombo G; Monzani V; Ceriani G; Lucchi T; Brignolo B; Manfellotto D; Caridi I; Corazza GR; Miceli E; Padula D; Fraternale G; Guasti L; Squizzato A; Maresca A; Liberato NL; Tognin T; Rozzini R; Bellucci FB; Muscaritoli M; Molfino A; Petrillo E; Dore M; Mete F; Gino M; Franceschi F; Gabrielli M; Perticone F; Perticone M; Bertolotti M; Mussi C; Borghi C; Strocchi E; Durazzo M; Fornengo P; Dallegri F; Ottonello LC; Salam K; Caserza L; Barbagallo M; Di Bella G; Annoni G; Bruni AA; Odetti P; Nencioni A; Monacelli F; Napolitano A; Brucato A; Valenti A; Castellino P; Zanoli L; Mazzeo M
    Eur J Intern Med; 2018 Jun; 52():e12-e14. PubMed ID: 29657108
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct oral anticoagulants in non-valvular atrial fibrillation in elderly: for a treatment adapted to patient profile.
    Tayaa S; Berrut G; de Decker L; Chevalet P
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Sep; 16(3):229-240. PubMed ID: 30063025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulation in atrial fibrillation in the elderly: the geriatrician point of view with a focus on the direct oral anticoagulants].
    Vogel T; Geny B; Kaltenbach G; Lang PO
    Rev Med Interne; 2015 Jan; 36(1):22-30. PubMed ID: 25234463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence.
    Bo M; Grisoglio E; Brunetti E; Falcone Y; Marchionni N
    Eur J Intern Med; 2017 Jun; 41():18-27. PubMed ID: 28343849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-management of oral anticoagulants with a whole blood prothrombin-time monitor in elderly patients with atrial fibrillation.
    Eldor A; Schwartz J
    Pathophysiol Haemost Thromb; 2002; 32(3):99-106. PubMed ID: 12372921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
    Başaran Ö; Dogan V; Beton O; Tekinalp M; Aykan AÇ; Kalaycıoğlu E; Bolat I; Taşar O; Şafak Ö; Kalçık M; Yaman M; İnci S; Altıntaş B; Kalkan S; Kırma C; Biteker M;
    J Thromb Thrombolysis; 2017 Feb; 43(2):157-165. PubMed ID: 27848065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial.
    De Caterina R; John Camm A
    Europace; 2016 Jan; 18(1):6-11. PubMed ID: 26450845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
    Marcy TR; Truong T; Rai A
    Consult Pharm; 2015 Nov; 30(11):644-56. PubMed ID: 26629800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for the choice of anticoagulant therapy for the prevention of stroke in patients with atrial fibrillation early after the marketing of direct oral anticoagulants in Italy.
    Marzona I; Roncaglioni MC; Avanzini F; Franzosi MG; Moia M;
    Eur J Intern Med; 2017 Jun; 41():e12-e14. PubMed ID: 28476324
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology, benefits, unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation and proposal of a management algorithm.
    Rosanio S; Keylani AM; D'Agostino DC; DeLaughter CM; Vitarelli A
    Int J Cardiol; 2014 Jul; 174(3):471-83. PubMed ID: 24814537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study.
    Mostaza JM; Suárez Fernández C; Castilla Guerra L; Suriñach JM; Tamarit JJ; Diaz Diaz JL; García Polo I; Santamaria EF; Fidalgo Fernández MA; de la Guerra Acebal C; Dávila Ramos MF; Ràfols C
    J Comp Eff Res; 2018 Mar; 7(3):223-232. PubMed ID: 29465254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anticoagulants for non-valvular atrial fibrillation.
    Xu B; Whitbourn R
    Heart Lung Circ; 2012 Aug; 21(8):463-7. PubMed ID: 22542860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
    Xu WW; Hu SJ; Wu T
    J Zhejiang Univ Sci B; 2017 Jul; 18(7):567-576. PubMed ID: 28681581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
    Bajaj NS; Kalra R; Patel N; Hashim T; Godara H; Ather S; Arora G; Pasala T; Whitfield TT; McGiffin DC; Ahmed MI; Lloyd SG; Limdi NA; Arora P
    PLoS One; 2016; 11(10):e0163608. PubMed ID: 27706224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials.
    Liew A; O'Donnell M; Douketis J
    J Thromb Haemost; 2014 Sep; 12(9):1419-24. PubMed ID: 24986568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.